Month: March 2020

London, March 24, 2020In response to a request from Borsa Italiana (the Italian Stock Exchange), CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) confirms that Hubertus Mühlhäuser resigned as CEO of CNH Industrial to pursue other interests. While Mr. Mühlhäuser offered to assist the Company while it searched for a successor, the Board determined that the Company had access to appropriate experience and skills and decided therefore to accept his resignation with immediate effect.CNH Industrial N.V. (NYSE: CNHI /MI: CNHI) is a global leader in the capital goods sector with established industrial experience, a wide range of products and a worldwide presence. Each of the individual brands belonging to the Company is a major international force in its specific industrial sector: Case IH, New Holland Agriculture and Steyr for tractors and agricultural...

Interim SPR1NT data showed presymptomatic babies with SMA treated with Zolgensma® (onasemnogene abeparvovec-xioi) soon after birth achieved age-appropriate motor milestones In addition to meeting both co-primary efficacy endpoints, nine of 22 patients in the completed pivotal STR1VE-US study demonstrated the “ability to thrive,” a stringent composite endpoint remarkable compared to untreated children with SMA Type 1 Ongoing START long-term follow-up study (cohort 2) demonstrated sustained durability of Zolgensma, including the achievement and maintenance of milestones in the follow up period, now up to 5 years post-dosing and up to 5+ years of age Cumulative safety data from 335 patients treated with Zolgensma indicate a safety profile consistent with previously-reported safety informationBasel, March 24, 2020 – AveXis, a Novartis company,...

COMMUNIQUE RELATIF AU DEPOT D’UN PROJET D’OFFRE PUBLIQUE DE RETRAITSUIVIE D’UN RETRAIT OBLIGATOIREVISANT LES ACTIONS DE LA SOCIETEINITIEE PARANDROMEDA INVESTISSEMENTS SASPRESENTEE PARLe Projet de Note d’information est disponible sur les sites Internet de l’AMF (www.amf-france.org) et d’APRIL (http://groupe.april.fr) et peut être obtenu sans frais au siège social d’Andromeda Investissements SAS (4 rue de Marivaux – 75002 Paris) et auprès de :Conformément aux dispositions de l’article 231-28 du règlement général de l’AMF, les autres informations relatives aux caractéristiques, notamment juridiques, financières et comptables d’Andromeda Investissements seront mises à la disposition du public au plus tard la veille du jour de l’ouverture de l’offre publique de retrait selon les mêmes modalités. Un communiqué de presse sera publié...

This press release is also available in Français (pdf) and Deutsch (pdf)…………. Vevey, March 24, 2020Nestlé S.A. maintains date of Annual General Meeting, changes format in light of coronavirusThe Board of Directors of Nestlé S.A. has confirmed that the Nestlé Annual General Meeting will take place as planned on April 23, 2020. This is to ensure the continued smooth functioning of the Group and will allow for the timely payment of the dividend.Out of concern for people’s health and in accordance with article 6a of COVID-19 Ordinance 2 of the Federal Council of March 16, 2020, shareholders will not be allowed to attend in person.Shareholders remain fully able to exercise their voting rights through the Independent Representative Hartmann Dreyer, Attorneys-at-law. Voting instructions can be given to the Independent...

This press release is also available in Français (pdf) and Deutsch (pdf)…………. Vevey, March 24, 2020Nestlé highlights innovation, digitalization and sustainability in 2019 Annual ReportNestlé today published its Annual Report for 2019. The Annual Report contains Nestlé’s Annual Review including Creating Shared Value highlights. It also contains the Corporate Governance & Compensation Reports and the Financial Statements, which were first published on February 13, 2020, and remain unchanged.Nestlé saw strong progress in 2019, with significant improvements in key operating and financial metrics. Organic growth reached 3.5%, fully in line with guidance. Profitability improved again as the underlying trading operating profit (UTOP) margin increased by 60 basis points to 17.6%, reaching the mid-term target announced...

SMA Type 2 patients between two and five years of age who received Dose B met the primary efficacy endpoint with a remarkable mean increase of 6.0 points in HFMSE scores from baseline to month 12, twice the clinically meaningful threshold, as measured by a validated, widely utilized and highly accepted scale developed specifically for older patients with SMA Nearly all patients (92%) in this cohort achieved a clinically meaningful ≥3-point increase during the study period, demonstrating a consistent response following gene therapy Increases observed in HFMSE reflect the preservation of motor neurons connected to key muscle groups impacted in SMA Type 2, allowing for motor development such as trunk control when rolling and sitting, and transitioning from lying to sitting Adverse events observed in STRONG were consistent with the AVXS-101...

Saint Herblain (France), March 24, 2020 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, today provided an update on its operations as the COVID-19 situation evolves.Valneva is actively managing its operations to maintain business continuity while taking measures to protect the health and wellbeing of its employees, their families and the local communities in which they live and work. The Company has instituted a work from home policy and for critical areas of its business that necessitate employees to be onsite, such as certain R&D and manufacturing functions, the Company is implementing strategies to promote additional social distancing. The continuous supply of Valneva’s products to its patients and customers is of utmost priority to the Company. Valneva’s scientific and commercial teams are in close dialogue...

Saint Herblain (France), le 24 mars 2020 – Valneva SE (“Valneva” ou “le Groupe”), société spécialisée dans les vaccins, fait aujourd’hui un point sur ses activités alors que l’évolution du COVID-19 se poursuit.Valneva gère activement toutes ses opérations afin d’assurer la continuité de ses activités tout en prenant des mesures pour protéger la santé et le bien-être de ses employés, de leurs familles et des communautés dans lesquelles ils vivent et travaillent. Le Groupe a institué une politique de télétravail et pour les activités critiques nécessitant une présence physique, telles que certaines fonctions de la R&D et de la production, Valneva a mis en place différentes stratégies visant à promouvoir davantage d’éloignement entre ses collaborateurs. Assurer une disponibilité continue de ses produits, pour ses clients comme pour...